168 related articles for article (PubMed ID: 18470848)
21. Synthesis and evaluation of photoreactive probes to elucidate iodide efflux in thyrocytes.
Derbré S; Lecat-Guillet N; Pillon F; Ambroise Y
Bioorg Med Chem Lett; 2009 Feb; 19(3):825-7. PubMed ID: 19103483
[TBL] [Abstract][Full Text] [Related]
22. Dynamic iodide trapping by tumor cells expressing the thyroidal sodium iodide symporter.
Dingli D; Bergert ER; Bajzer Z; O'connor MK; Russell SJ; Morris JC
Biochem Biophys Res Commun; 2004 Dec; 325(1):157-66. PubMed ID: 15522214
[TBL] [Abstract][Full Text] [Related]
23. Rat sodium iodide symporter allows using lower dose of 131I for cancer therapy.
Mitrofanova E; Unfer R; Vahanian N; Link C
Gene Ther; 2006 Jul; 13(13):1052-6. PubMed ID: 16525480
[TBL] [Abstract][Full Text] [Related]
24. A nonradioactive iodide uptake assay for sodium iodide symporter function.
Waltz F; Pillette L; Ambroise Y
Anal Biochem; 2010 Jan; 396(1):91-5. PubMed ID: 19733144
[TBL] [Abstract][Full Text] [Related]
25. Iodination of proteins in TPO transfected thyroid cancer cells is independent of NIS.
Wenzel A; Upadhyay G; Schmitt TL; Loos U
Mol Cell Endocrinol; 2003 Dec; 213(1):99-108. PubMed ID: 15062578
[TBL] [Abstract][Full Text] [Related]
26. Enhanced expression of adenovirus-mediated sodium iodide symporter gene in MCF-7 breast cancer cells with retinoic acid treatment.
Lim SJ; Paeng JC; Kim SJ; Kim SY; Lee H; Moon DH
J Nucl Med; 2007 Mar; 48(3):398-404. PubMed ID: 17332617
[TBL] [Abstract][Full Text] [Related]
27. Iodide kinetics and experimental (131)I therapy in a xenotransplanted human sodium-iodide symporter-transfected human follicular thyroid carcinoma cell line.
Smit JW; Schröder-van der Elst JP; Karperien M; Que I; Stokkel M; van der Heide D; Romijn JA
J Clin Endocrinol Metab; 2002 Mar; 87(3):1247-53. PubMed ID: 11889195
[TBL] [Abstract][Full Text] [Related]
28. Functional sodium iodide symporter expression in breast cancer xenografts in vivo after systemic treatment with retinoic acid and dexamethasone.
Willhauck MJ; Sharif-Samani B; Senekowitsch-Schmidtke R; Wunderlich N; Göke B; Morris JC; Spitzweg C
Breast Cancer Res Treat; 2008 May; 109(2):263-72. PubMed ID: 17636401
[TBL] [Abstract][Full Text] [Related]
29. Advances in Na(+)/I(-) symporter (NIS) research in the thyroid and beyond.
Dohán O; Carrasco N
Mol Cell Endocrinol; 2003 Dec; 213(1):59-70. PubMed ID: 15062574
[TBL] [Abstract][Full Text] [Related]
30. Comparison of expressed human and mouse sodium/iodide symporters reveals differences in transport properties and subcellular localization.
Dayem M; Basquin C; Navarro V; Carrier P; Marsault R; Chang P; Huc S; Darrouzet E; Lindenthal S; Pourcher T
J Endocrinol; 2008 Apr; 197(1):95-109. PubMed ID: 18372236
[TBL] [Abstract][Full Text] [Related]
31. Radioiodine therapy of hepatoma using targeted transfer of the human sodium/iodide symporter gene.
Chen L; Altmann A; Mier W; Eskerski H; Leotta K; Guo L; Zhu R; Haberkorn U
J Nucl Med; 2006 May; 47(5):854-62. PubMed ID: 16644756
[TBL] [Abstract][Full Text] [Related]
32. Radiation-induced thyroid stunning: differential effects of (123)I, (131)I, (99m)Tc, and (211)At on iodide transport and NIS mRNA expression in cultured thyroid cells.
Lundh C; Lindencrona U; Postgård P; Carlsson T; Nilsson M; Forssell-Aronsson E
J Nucl Med; 2009 Jul; 50(7):1161-7. PubMed ID: 19525464
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of potential sodium-iodide symporter (NIS) inhibitors using a secondary Fischer rat thyroid follicular cell (FRTL-5) radioactive iodide uptake (RAIU) assay.
Buckalew AR; Wang J; Murr AS; Deisenroth C; Stewart WM; Stoker TE; Laws SC
Arch Toxicol; 2020 Mar; 94(3):873-885. PubMed ID: 32065294
[TBL] [Abstract][Full Text] [Related]
34. Modulation of iodide uptake by dialkyl phthalate plasticisers in FRTL-5 rat thyroid follicular cells.
Wenzel A; Franz C; Breous E; Loos U
Mol Cell Endocrinol; 2005 Dec; 244(1-2):63-71. PubMed ID: 16289305
[TBL] [Abstract][Full Text] [Related]
35. The Sodium/Iodide Symporter (NIS): Molecular Physiology and Preclinical and Clinical Applications.
Ravera S; Reyna-Neyra A; Ferrandino G; Amzel LM; Carrasco N
Annu Rev Physiol; 2017 Feb; 79():261-289. PubMed ID: 28192058
[TBL] [Abstract][Full Text] [Related]
36. Effects of dose, intervention time, and radionuclide on sodium iodide symporter (NIS)-targeted radionuclide therapy.
Shen DH; Marsee DK; Schaap J; Yang W; Cho JY; Hinkle G; Nagaraja HN; Kloos RT; Barth RF; Jhiang SM
Gene Ther; 2004 Jan; 11(2):161-9. PubMed ID: 14712300
[TBL] [Abstract][Full Text] [Related]
37. Histidine residue at position 226 is critical for iodide uptake activity of human sodium/iodide symporter.
Wu SL; Ho TY; Liang JA; Hsiang CY
J Endocrinol; 2008 Nov; 199(2):213-9. PubMed ID: 18708479
[TBL] [Abstract][Full Text] [Related]
38. AFP promoter enhancer increased specific expression of the human sodium iodide symporter (hNIS) for targeted radioiodine therapy of hepatocellular carcinoma.
Ma XJ; Huang R; Kuang AR
Cancer Invest; 2009 Jul; 27(6):673-81. PubMed ID: 19241193
[TBL] [Abstract][Full Text] [Related]
39. The BeWo choriocarcinoma cell line as a model of iodide transport by placenta.
Manley SW; Li H; Mortimer RH
Placenta; 2005 May; 26(5):380-6. PubMed ID: 15850642
[TBL] [Abstract][Full Text] [Related]
40. Ectopic expression of the thyroperoxidase gene augments radioiodide uptake and retention mediated by the sodium iodide symporter in non-small cell lung cancer.
Huang M; Batra RK; Kogai T; Lin YQ; Hershman JM; Lichtenstein A; Sharma S; Zhu LX; Brent GA; Dubinett SM
Cancer Gene Ther; 2001 Aug; 8(8):612-8. PubMed ID: 11571539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
